BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirschberg AL, Gidlöf S, Falhammar H, Frisén L, Almqvist C, Nordenskjöld A, Nordenström A. Reproductive and Perinatal Outcomes in Women with Congenital Adrenal Hyperplasia: A Population-based Cohort Study. J Clin Endocrinol Metab 2021;106:e957-65. [PMID: 33135723 DOI: 10.1210/clinem/dgaa801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kocova M, Concolino P, Falhammar H. Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Front Endocrinol 2022;12:788812. [DOI: 10.3389/fendo.2021.788812] [Reference Citation Analysis]
2 Farghaly HS, Metwalley KA, Raafat DM, Saied GM, Gabri MF, Algowhary M. Association between vascular endothelial dysfunction and the inflammatory marker neopterin in patients with classic congenital adrenal hyperplasia. Atherosclerosis 2021;328:38-43. [PMID: 34091068 DOI: 10.1016/j.atherosclerosis.2021.05.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mallappa A, Merke DP. Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nat Rev Endocrinol. [DOI: 10.1038/s41574-022-00655-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nordenström A, Lajic S, Falhammar H. Clinical outcomes in 21-hydroxylase deficiency. Curr Opin Endocrinol Diabetes Obes 2021;28:318-24. [PMID: 33741777 DOI: 10.1097/MED.0000000000000625] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Carrière C, Sarfati C, Téjédor I, Dulon J, Chakhtoura Z, Courtillot C, Bachelot A. Classical and non-classical congenital adrenal hyperplasia: what is the difference in subsequent fertility? Ann Endocrinol (Paris) 2022:S0003-4266(22)00054-3. [PMID: 35489415 DOI: 10.1016/j.ando.2022.04.007] [Reference Citation Analysis]
6 Delai A, Gomes PM, Foss-Freitas MC, Elias J, Antonini SR, Castro M, Moreira AC, Mermejo LM. Hyperinsulinemic-euglycaemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2021:dgab767. [PMID: 34693966 DOI: 10.1210/clinem/dgab767] [Reference Citation Analysis]
7 Falhammar H, Frisén L, Hirschberg AL, Nordenskjöld A, Almqvist C, Nordenström A. Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-Based National Cohort Study. J Clin Endocrinol Metab 2021:dgab712. [PMID: 34601607 DOI: 10.1210/clinem/dgab712] [Reference Citation Analysis]
8 Hahner S, Ross RJ, Arlt W, Bancos I, Burger-Stritt S, Torpy DJ, Husebye ES, Quinkler M. Adrenal insufficiency. Nat Rev Dis Primers 2021;7:19. [PMID: 33707469 DOI: 10.1038/s41572-021-00252-7] [Reference Citation Analysis]